How are the media reporting COVID-19? What has happened to stories on other health problems such as HIV, malaria and infant deaths? Find out in the second in our series of podcasts about the pandemic
For Pandemicast 2, senior journalists from India and West Africa join Mark Chataway in Western Europe and Professor Ken Rabin, an editor at the Journal of Health Communications, who has decades of experience in the US, but now lives in Warsaw. They look at how journalists around the world are covering the COVID-19 pandemic and what hope we have of getting some oxygen for other vital topics such as malaria, non-communicable diseases and neglected tropical diseases.
How the media are reporting COVID-19 is affecting national policy around the world and there are big differences between print and broadcast in many countries.
- Has the Ebola experience changed how West African journalists look at outbreaks and pandemics?
- How journalists in Africa and Asia came to be led less by the Western news agenda
- The impact of presidential politics in Poland and the US and the “re-emergence of Stalinism in American press conferences”
In Pandemicast 1, the first of our new Pandemicast podcast series, we looked at the way that different countries around the world are dealing with the emergence of the pandemic. Mark Chataway was joined by colleagues from India, Kenya, Italy, the UK and the USA. He asked why policymakers in these countries have made such divergent choices.
Dr. Ken Rabin has more than fifty years of experience in public affairs, marketing communications and education, almost entirely in healthcare and science. Currently, he is a senior counselor at Alfa Communications in Warsaw, a partner in Baird’s Communications Management Consultants and a member of the editorial board of The Journal of Health Communication. Ken specializes in health policy and finance, cancer and infectious disease communications (HIV/AIDS and vaccines, including the launch of GAVI and of the first HiB vaccine). His clients have included Johnson and Johnson (for whom he helped develop and launch the Campaign for Nursing’s Future), Merck, Sirtex (whose SIRT liver cancer treatment technology he has helped represent in Poland for more than 10 years), L’oreal – UNESCO “For Women in Science”, PhRMA and IFPMA. His campaigns have won a Silver Anvil, Gold Quill, and Big Apple Award of the NY PRSA.
Mark Chataway was the first director of communications for GMHC in New York, the largest AIDS service organisation in the USA when the AIDS epidemic first came to braod public attention. He has worked in infectious diseases, vaccines and pandemic preparation since